Evolva Holding SA, a biosynthetic company, discovers and develops ingredients and processes for food, nutrition, and pharmaceutical products. The company uses fermentation-based platform for the production of ingredients. Its nutrition and consumer products include Pomecins, which are compounds that prevent mould and yeast growth, and are used in food and crop protection and health care industries; saffron, a spice for food coloring and flavoring; stevia, a natural sweetener; and vanilla for use in confectionery and dairy products. The company also focuses on developing small molecule drugs, including EV-077 for the treatment of diabetic complications; and EV-035, a novel bacterial type II topoisomerase inhibitor that address the threat of bad bugs. It operates in Switzerland, Denmark, the United States, and India. Evolva Holding SA has collaboration or partnership agreements with International Flavors & Fragrances Inc., BASF, Roquette, and Roche. The company is based in Reinach, Switzerland.
